Welcome to our dedicated page for Kenvue SEC filings (Ticker: KVUE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Kenvue Inc. (NYSE: KVUE) SEC filings, giving investors a primary source for the company’s regulatory disclosures. As the world’s largest pure-play consumer health company by revenue, Kenvue uses its SEC reports to detail financial performance, risk factors, governance matters and significant corporate events related to its portfolio of brands such as Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena®, Tylenol® and Zyrtec®.
Among the most important documents for KVUE are current reports on Form 8-K. In 2025, Kenvue filed several 8-Ks to furnish quarterly earnings press releases and to describe leadership changes, preliminary financial results and the Board’s comprehensive review of strategic alternatives. A key 8-K filed on November 3, 2025 outlines an Agreement and Plan of Merger with Kimberly-Clark Corporation, under which a Kimberly-Clark subsidiary will merge with and into Kenvue and Kenvue will ultimately become part of a wholly owned Kimberly-Clark subsidiary. That filing explains the merger structure, the cash and stock consideration for each share of Kenvue common stock, conditions to closing, and termination and fee provisions.
Investors can also use Kenvue’s filings to understand how management presents non-GAAP financial measures. The company’s 8-K earnings materials define metrics such as Adjusted gross profit margin, Adjusted operating income and margin, Adjusted net income, Adjusted diluted earnings per share, Adjusted EBITDA margin, Adjusted effective tax rate, Free cash flow and Organic sales, and reconcile them to the most comparable U.S. GAAP measures. These disclosures clarify how Kenvue evaluates operating efficiency, profitability and cash generation over time.
On this page, Stock Titan surfaces Kenvue’s SEC submissions as they are made available on EDGAR and pairs them with AI-powered summaries to explain the key points in plain language. Users can quickly scan new 10-K and 10-Q reports when filed, review 8-Ks for material events such as the Kimberly-Clark merger agreement or leadership transitions, and examine any proxy materials related to shareholder votes. This combination of real-time filings access and AI explanations helps investors follow how regulatory disclosures may affect KVUE shareholders and the future of the Kenvue business within the consumer health sector.
Kenvue Inc. Chief Operations Officer Meredith Stevens reported routine equity compensation activity involving Restricted Stock Units that vested into common stock. She exercised RSUs corresponding to 5,169.62 shares of common stock, while 2,096 shares were withheld to cover tax obligations, including FICA, rather than sold on the market. Following these transactions, she directly holds 93,621.01 shares of Kenvue common stock and 10,675.92 RSUs, which each correspond 1-for-1 with common stock. One RSU award is scheduled to vest in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, contingent on her continued service.
Kenvue Inc. Chief People Officer Luani Alvarado exercised restricted stock units into common stock and used part of the resulting shares to cover taxes. On March 10, 2026, RSU awards totaling 4,222.22 units were converted 1-for-1 into common shares.
To satisfy tax obligations, 2,078 common shares were withheld at prices of $17.96 and $18.16 per share, as noted in the footnotes. Following these transactions, Alvarado directly held 61,415.440 shares of Kenvue common stock and 8,693.150 RSUs, including units from dividend reinvestment.
Kenvue Inc. Group President EMEA & LA Carlton Lawson exercised restricted stock units that converted into 6,157.82 shares of common stock on 03/10/2026. All shares from this vesting were retained, with related taxes paid in cash rather than through share withholding.
Following these transactions, Lawson directly holds 111,415.02 shares of Kenvue common stock and 12,313.63 restricted stock units, which each correspond 1-for-1 to common shares. The activity reflects compensation-related equity vesting rather than an open-market purchase or sale.
Kenvue Inc. executive Lawson Carlton, Group President EMEA & LA, exercised restricted stock units that converted into 7736.1700 shares of common stock on 2026-03-05. The reporting person retained all shares acquired upon vesting and paid related tax withholdings in cash.
The restricted stock unit award corresponds 1-for-1 with Kenvue common stock and vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to continued service. Following the transaction, direct common stock holdings totaled 105257.2000 shares, including shares acquired in dividend reinvestment transactions.
Kenvue Inc. Chief People Officer Luani Alvarado reported equity award activity involving restricted stock units and common shares. On the same date, 4,289.080 restricted stock units were exercised or converted into 4,289.080 shares of common stock at a stated price of $0.0000 per share.
Following these conversions, directly held common stock increased to 61,365.220 shares before a separate tax-related transaction. In a related move, 2,094 common shares, valued at $18.25 per share, were withheld to cover tax obligations upon vesting, leaving 59,271.220 common shares directly owned. Restricted stock units outstanding after these events totaled 4,290.220 units, corresponding one-for-one with common stock and vesting in three equal installments through 2027.
Kenvue Inc. Chief Operations Officer Meredith Stevens reported equity award activity involving restricted stock units and common stock. On March 5, 2026, she exercised or converted 6,178.21 restricted stock units, which correspond 1-for-1 to Kenvue common stock, into 6,178.21 shares of common stock.
In a related tax-withholding transaction, 1,677 common shares were withheld at $18.25 per share to cover taxes due upon vesting of the restricted stock units. After these transactions, she directly held 90,547.39 common shares and 6,177.23 restricted stock units, with the award scheduled to vest in three equal installments on March 5, 2025, 2026, and 2027, subject to continued service.
Kenvue Inc. VP & Chief Accounting Officer Heather Howlett reported equity award activity involving restricted stock units and common stock. On 03/05/2026, 2,722.87 restricted stock units, which correspond 1-for-1 with Kenvue common stock, were converted into 2,722.87 common shares. On the same date, 933 common shares at $18.25 per share were withheld to cover taxes due at vesting, leaving her with 32,988.37 common shares held directly. Following the transaction, 2,721.89 restricted stock units remained outstanding, and her holdings also include shares acquired through dividend reinvestment.
Kenvue Inc. reported that its General Counsel, Matthew Orlando, received a grant of 122,286 Restricted Stock Units (RSUs) on March 2, 2026. These RSUs were acquired at a price of $0.00 per unit as a compensation award and now represent his total reported RSU holdings.
The units correspond on a 1-for-1 basis with Kenvue common stock. The award is scheduled to vest in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029, provided he continues in service through each vesting date.
Kenvue Inc. reported that Chief Tech & Data Officer Michael Wondrasch acquired a grant of 79,407 restricted stock units (RSUs), each corresponding 1-for-1 to Kenvue common stock. The award vests in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029, contingent on his continued service with the company through each vesting date.
Kenvue Inc. reported that Group President LATAM Leonardo Curado Gomes de Lemos acquired 13,234 restricted stock units as an equity award. These units correspond 1-for-1 with Kenvue common stock. The award vests in three equal installments on March 2 of 2027, 2028, and 2029, contingent on continued service.